1. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2.
- Author
-
Fachi JL, Sécca C, Rodrigues PB, Mato FCP, Di Luccia B, Felipe JS, Pral LP, Rungue M, Rocha VM, Sato FT, Sampaio U, Clerici MTPS, Rodrigues HG, Câmara NOS, Consonni SR, Vieira AT, Oliveira SC, Mackay CR, Layden BT, Bortoluci KR, Colonna M, and Vinolo MAR
- Subjects
- Animals, Inflammasomes immunology, Male, Mice, Mice, Inbred C57BL, Signal Transduction immunology, Acetates immunology, Clostridioides difficile immunology, Clostridium Infections immunology, Enterocolitis, Pseudomembranous immunology, Immunity, Innate immunology, Neutrophils immunology, Receptors, G-Protein-Coupled immunology
- Abstract
Antibiotic-induced dysbiosis is a key predisposing factor for Clostridium difficile infections (CDIs), which cause intestinal disease ranging from mild diarrhea to pseudomembranous colitis. Here, we examined the impact of a microbiota-derived metabolite, short-chain fatty acid acetate, on an acute mouse model of CDI. We found that administration of acetate is remarkably beneficial in ameliorating disease. Mechanistically, we show that acetate enhances innate immune responses by acting on both neutrophils and ILC3s through its cognate receptor free fatty acid receptor 2 (FFAR2). In neutrophils, acetate-FFAR2 signaling accelerates their recruitment to the inflammatory sites, facilitates inflammasome activation, and promotes the release of IL-1β; in ILC3s, acetate-FFAR2 augments expression of the IL-1 receptor, which boosts IL-22 secretion in response to IL-1β. We conclude that microbiota-derived acetate promotes host innate responses to C. difficile through coordinate action on neutrophils and ILC3s., Competing Interests: Disclosures: The authors declare no competing interests exist., (© 2019 Fachi et al.)
- Published
- 2020
- Full Text
- View/download PDF